Introducing Dr. Beatriz Moiraghi! She has worked as a hematologist for 25 years in Argentina and has been a Max partner physician since 2002. Learn more about her below.
Describe a typical work week:
On a typical workday, I arrive at the hospital early, at 7 a.m. I not only see patients from the Max program but also more than 250 patients with chronic myeloid leukemia.
How many patients are you treating in the program?
In the The Max Foundation program, I see approximately ten patients.
Is there a patient experience that stayed with you?
I have many stories about my patients, particularly when they receive their molecular test results and I can explain that everything is more than fine with the disease. I always emphasize adherence to the daily medication without missing any doses. Another memory is the look of surprise on their faces, relief at receiving treatment and hope for the future.
When you’re not working, what do you like to do for fun?
I watch movies and TV series, and I read all kinds of novels. What I enjoy most is traveling, discovering new places, and meeting local people.
What languages do you speak?
I speak Spanish.
What is your favorite food?
I like to eat salmon.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
This year, we’re celebrating 25 years of partnership with Novartis. Together, we’ve provided access to treatment for more than 100,00 people living with cancer in low- and middle-income countries. Below, eight patients from four locations where we operate share their stories. They talk about how they were diagnosed, the impact of having treatment, and what’s….
We’re often reminded of why we put an effort in supporting people facing cancer – whether it comes through a patient story or through an organization’s investment in our work. This week, we humbly received another reminder: on Friday, May 22, the International Chronic Myeloid Leukemia (CML) Foundation awarded our CEO Pat Garcia-Gonzalez with the inaugural ERSAP (Emerging Region Support and Partnership) Prize. The iCMLf Directors and Scientific Advisors selected Pat because of her continued commitment, and The Max Foundation’s aim, to help people face cancer with dignity and hope.
Over the past several months, we have been training, fundraising, and preparing to conquer Mt. Kinabalu, and now we’re counting down the days until our team meets at the foot of the mountain for the big climb. Why climb a mountain, you might ask?
